Mindr Quarterly Update
Dear Friends of Mindr,
I hope this message finds you well. It’s been a transformative year for us at Mindr, and I’m thrilled to share our latest updates and milestones with you.
For those who haven’t met me yet, I am Adam Schultz, Co-Founder and CEO of Mindr. Dr Inna Marquard has passed me the baton following our successful field trial (more on this below). I am honored by the trust and confidence of our team as I take on this challenge, and we thank Inna for her continuing scientific stewardship and support as Mindr’s Chief Science Advisor.
Additionally, we welcome Ariana Myers as our new Co-Founder and COO. Ariana has been instrumental in developing new partnerships, deepening existing relationships, refining our go-to-market strategy, and preparing us for what’s next.
Over the past year, we’ve made tremendous strides.
Our 90-day proof of concept pilot program, completed in Q1 of last year, exceeded our expectations with an impressive 88% activity completion rate and significant improvements in client-reported cognitive and quality of life metrics. On the back of this success, we signed up our first paying customers and were honored to present our findings at the Alzheimer’s Association International Conference in Amsterdam last summer. Additionally we were accepted into Startup Health, which has both expanded our network and raised our profile.
When plans to raise capital for our MVP fell victim to last year’s adverse fundraising environment, we didn’t falter, we pivoted. We successfully recruited a dedicated team of developers and instructional designers willing to work for equity and doubled our beta participant waitlist through marketing partnerships. These successes underscore both the inspirational value of Mindr’s mission as well as the team’s resilience and commitment to revolutionizing preventive cognitive health.
After 9 months of development, feedback, and refinement, we are nearly ready to begin alpha testing our V1 MVP next month, with a beta launch slated for December. Our product development is being enhanced with the support of Teepa Snow’s A Positive Approach to Care, both in terms of content quality assurance as well as helping us recruit additional beta participants.
We are preparing to launch a new fundraising effort to support our next phase of growth. This round will focus on hardening our platform for launch, ensuring HIPAA compliance, scaling infrastructure, launching our phase 1 B2C go-to-market strategy, enabling clinical efficacy studies, and developing V2 product, which will use data collected from the V1 Product to train AI activity generators and our ML planning engine. If you are interested in participating learning more about investing with us, please make sure you are on our prospective investor list.
As we gear up for our beta launch, we invite you to sign up for our beta program and be among the first to experience our innovative approach to dementia prevention! If you know anyone interested in our mission, please encourage them to subscribe to our newsletter for regular updates (form is at the bottom of the page).
Thank you for your unwavering support. We couldn’t have come this far without you. Stay tuned for more exciting updates!
Best regards,
Adam Schultz
CEO, Mindr
adam@mindr.us